“Historically, drug developers face limited incentives to address the needs of patients with lower economic potential, as including them in trials often incurs costs that don’t align with anticipated returns. But if we can reduce or eliminate these costs, we could shift this paradigm," says Dr. Jo Varshney in this Clinical Trials Arena article on the World Health Organization's new guidance on diversity. Read more: bit.ly/40po1pR
VeriSIM Life
Biotechnology Research
San Francisco, California 2,889 followers
Introducing BIOiSIM, an AI-driven drug development engine designed to de-risk and inform R&D decision-making.
About us
VeriSIM Life is building AI enabled biosimulation models. VeriSIM will tackle one of the biggest obstacles of drug development: animal testing for drug development. Animal testing is slow, ethically questionable, and doesn't act as much of a filter: 92% of all drug candidates that pass this preclinical testing never make it to market. VeriSIM's solution is to create disease-specific biosimulation models, which allow researchers at pharma companies to model in software how a drug will interact in animals. This will allow researchers to test 1000x more potential candidates in the same unit of time, ensuring that drugs that do make it to (human) clinical trials are far more likely to work, and therefore saving millions in annual costs.
- Website
-
http://verisimlife.com/
External link for VeriSIM Life
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- San Francisco, California
- Type
- Privately Held
- Founded
- 2017
Locations
-
Primary
Get directions
505 Montgomery St
San Francisco, California, US
Employees at VeriSIM Life
-
Joseph Miller
Managing Partner at Morpheus Ventures
-
Peter Gissel
Veteran Software Engineer championing design and development best practices for high quality software
-
Jeff Barrett
Chief Science Officer, Aridhia Digital Research Environment
-
Alexander Harmsen
PortfolioPilot.com - your personal AI financial advisor
Updates
-
"Fortunately, AI can help bring underrepresented patient populations into clinical trials through 'virtual patients,'" Dr. Jo Varshney explains in this PM360 Magazine article. "Virtual patients are computer-generated models that mimic the physiological and biological diversity seen in real patients, and they allow us to simulate the inclusion of underrepresented groups into the clinical trial process." Read more: bit.ly/4h5geme
-
-
Dr. Jo Varshney is thrilled to be included as a leader at the San Francisco Business Times Bizwomen #MentoringMonday event in February featuring the region’s top businesswomen sharing their secrets to success. Learn more and buy tickets: bit.ly/400phOL
-
-
VeriSIM Life reposted this
The WHO’s guidance provides direction on diversity and how to include patients who are pregnant, lactating and from low-middle income countries. To learn more we spoke to VeriSIM Life founder and CEO Dr Jo Varshney, Michael Young, co-founder of Lindus Health, Oren Cohen, president of clinical pharmacology of clinical research organisation (CRO) Fortrea, Cognivia CEO Dr Dominique Demolle and eClinical Solutions senior director Jason Housley Click here for the full article - https://lnkd.in/dYUPfuYT #clinicaltrials #trialdiversity #clinicaloperations #clinicalresearch #clinicalstudies
-
-
Attending the JPM Healthcare Conference in January? Meet with our team to learn how we can help you expand your pipeline and get your next breakthrough drug to market faster. https://hubs.li/Q02_jTr30
-
-
CEO & Founder Dr. Jo Varshney was excited to be a speaker at the UBS Tech Conference last week on the panel "AI Saving Lives" alongside other respected industry leaders. And it was great to catch up with other Founders & CEOs including Ashley Zehnder, Co-founder and CEO at Fauna Bio!
-
-
VeriSIM Life reposted this
Mentorship has shaped my life in countless ways, providing guidance, encouragement, and lessons that have fueled my growth. As we approach #BizWomen Mentoring Monday, I’m reminded of the power of these relationships to inspire and empower and excited to pay it forward. Join me and an amazing group of mentors for BizWomen Mentoring Monday—a unique opportunity to connect, share insights, and build meaningful relationships with mentors and mentees alike. #MentorshipMatters #Leadership #MentoringMonday https://lnkd.in/gsXAeeR7
Bizwomen Mentoring Monday - San Francisco Business Times
bizjournals.com
-
Attending the UBS Global Technology Conference in December? Dr. Jo Varshney will be speaking on the panel “AI Saving Lives” alongside other industry leaders on December 4th including Mara Aspinall, Ilumina Ventures; Tom Walsh, VP, Generative AI Strategy and Governance, Quest Diagnostics Inc; and Kurt Haggstrom, Chief Commercial Officer, Synchron. View the agenda: bit.ly/3VcR5h7
-